abbviehero

logo-abbvie

abbvie3

abbvie2

abbvie1

AbbVie Gallery

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. 

It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; and Genmab A/S. The company was founded in 2013 and is based in North Chicago, Illinois.

Sweet 16 CEOs Target vs. Ford

pexels-photo-4397810

Sweet 16 winner

TiiCKER Team

Drew Hall

Even though 2021 marks 40 years since Cuban-born Roberto Goizueta was named CEO of the Coca-Cola Co. (Tii:KO) and the first Hispanic to lead a publicly-traded company, today, only 16 execs oversee Fortune 500 companies. Let's look at four of them.

National Hispanic Heritage Month: The Challenges Facing Today’s Leading Executives

Target Corp. defeated Ford Motor Co. to win TiiCKER’s inaugural Sweet 16 CEOs Competition and Sweepstakes. Over the last two weeks, the tournament has pit execs – representing both their alma maters and the companies they lead – against each other while offering chances to win valuable prizes.

Sweet 16 CEOs Championship: Target Tops Ford to Win First TiiCKER Title

TiiCKER’s Sweet 16 CEOs Competition and Sweepstakes has pit execs – representing both their alma maters and the publicly traded companies they lead – against each other while offering chances to win valuable prizes. With just two teams left, let’s take a quick look back.

Sweet 16 CEOs Finals: Target Corp. vs. Ford Motor for the TiiCKER Title

Discover brands image

Collect rewards image

Connect Accounts image

Create profile image

Create a profile

How it works - Create a Profile

Connect accounts

How it works - Connect Accounts

Discover brands

How it works - Discover Brands

Collect rewards

How it works - Collect Rewards

TiiCKER offers a completely personalized experience and first-ever way to view your stock portfolio, trade for free and invest in new companies while viewing your perks in one place! 

How it works

Homepage - How It Works

TiiCKER was created for fan-first, brand-first public companies—with exclusive perks served-up weekly to shareholders. Own stock? Connect your brokerage account to view more than 130 perks waiting for you right now!  

Start earning perks <span>today</span>

Join Now CTA

## Congratulations! You *qualify* for a TiiCKER *perk*

## Congratulations! You *may qualify* for a TiiCKER *perk*

TiiCKER Perk CTA

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism.